Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Otorhinolaryngology

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    February 2018
  1. CHAN KKW, Saluja R, Delos Santos K, Lien K, et al
    Neoadjuvant Treatments for Locally Advanced, Resectable Esophageal Cancer: A Network Meta-Analysis.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31312.
    PubMed     Text format     Abstract available


    January 2018
  2. WANG YQ, Chen YP, Zhang Y, Jiang W, et al
    Prognostic significance of tumor-infiltrating lymphocytes in non-disseminated nasopharyngeal carcinoma: A large-scale cohort study.
    Int J Cancer. 2018 Jan 27. doi: 10.1002/ijc.31279.
    PubMed     Text format     Abstract available


  3. LEEMAN JE, McBride SM, Spielsinger D, Sherman EJ, et al
    Head and Neck Cancers Associated with Exposure to the September 11, 2001 World Trade Center Terrorist Attacks.
    Int J Cancer. 2018 Jan 25. doi: 10.1002/ijc.31277.
    PubMed     Text format     Abstract available


  4. MERMOD M, Hiou-Feige A, Bovay E, Roh V, et al
    Mouse model of post-surgical primary tumor recurrence and regional lymph node metastasis progression in HPV-related head and neck cancer.
    Int J Cancer. 2018 Jan 4. doi: 10.1002/ijc.31240.
    PubMed     Text format     Abstract available


    December 2017
  5. SIEW SS, Martinsen JI, Kjaerheim K, Sparen P, et al
    Occupational exposure to wood dust and risk of nasal and nasopharyngeal cancer: A case-control study among men in four nordic countries-With an emphasis on nasal adenocarcinoma.
    Int J Cancer. 2017;141:2430-2436.
    PubMed     Text format     Abstract available


  6. STANGL S, Tontcheva N, Sievert W, Shevtsov M, et al
    Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology
    Int J Cancer. 2017 Dec 13. doi: 10.1002/ijc.31213.
    PubMed     Text format     Abstract available


    November 2017
  7. DOSSUS L, Franceschi S, Biessy C, Navionis AS, et al
    Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study.
    Int J Cancer. 2017 Nov 23. doi: 10.1002/ijc.31172.
    PubMed     Text format     Abstract available


  8. YUNHONG T, Jie L, Yunming T, Guoqian Z, et al
    Efficacy and safety of anti-EGFR agents administered concurrently with standard therapies for patients with head and neck squamous cell carcinoma: A systematic review and meta-analysis of randomized controlled trials.
    Int J Cancer. 2017 Nov 16. doi: 10.1002/ijc.31157.
    PubMed     Text format     Abstract available


  9. HU J, Li H, Luo X, Li Y, et al
    The role of oxidative stress in EBV lytic reactivation, radioresistance and the potential preventive and therapeutic implications.
    Int J Cancer. 2017;141:1722-1729.
    PubMed     Text format     Abstract available


    October 2017
  10. MAO L, Zhao ZL, Yu GT, Wu L, et al
    gamma-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma.
    Int J Cancer. 2017 Oct 19. doi: 10.1002/ijc.31115.
    PubMed     Text format     Abstract available


  11. HOFFMANN M, Pasch S, Schamberger T, Maneck M, et al
    Diagnostic pathology of early systemic cancer: ERBB2 gene amplification in single disseminated cancer cells determines patient survival in operable esophageal cancer.
    Int J Cancer. 2017 Oct 16. doi: 10.1002/ijc.31108.
    PubMed     Text format     Abstract available


  12. ZHU L, Sturgis EM, Zhang H, Lu Z, et al
    Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.
    Int J Cancer. 2017;141:1355-1364.
    PubMed     Text format     Abstract available


    September 2017
  13. KLINGHAMMER K, Keller J, George J, Hoffmann J, et al
    A phosphoarray platform is capable of personalizing kinase inhibitor therapy in head and neck cancers.
    Int J Cancer. 2017 Sep 14. doi: 10.1002/ijc.31045.
    PubMed     Text format     Abstract available


  14. LIU J, Lv L, Gong J, Tan Y, et al
    Overexpression of F-box only protein 31 predicts poor prognosis and deregulates p38alpha- and JNK-mediated apoptosis in esophageal squamous cell carcinoma.
    Int J Cancer. 2017 Sep 14. doi: 10.1002/ijc.31040.
    PubMed     Text format     Abstract available


    August 2017
  15. FOUNTZILAS G, Psyrri A, Giannoulatou E, Tikas I, et al
    Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe.
    Int J Cancer. 2017 Aug 31. doi: 10.1002/ijc.31023.
    PubMed     Text format     Abstract available


  16. SHIVAPPA N, Hebert JR, Rosato V, Garavello W, et al
    Inflammatory potential of diet and risk of oral and pharyngeal cancer in a large case-control study from Italy.
    Int J Cancer. 2017;141:471-479.
    PubMed     Text format     Abstract available


    July 2017
  17. WANG YK, Chuang YS, Wu TS, Lee KW, et al
    Endoscopic screening for synchronous esophageal neoplasia among patients with incident head and neck cancer: Prevalence, risk factors and outcomes.
    Int J Cancer. 2017 Jul 30. doi: 10.1002/ijc.30911.
    PubMed     Text format     Abstract available


  18. KAWAKITA D, Amy Lee YC, Turati F, Parpinel M, et al
    Dietary fiber intake and head and neck cancer risk: A pooled analysis in the International Head and Neck Cancer Epidemiology consortium.
    Int J Cancer. 2017 Jul 14. doi: 10.1002/ijc.30886.
    PubMed     Text format     Abstract available


  19. ZAMORA-ROS R, Beraud V, Franceschi S, Cayssials V, et al
    Consumption of fruits, vegetables, and fruit juices and differentiated thyroid carcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
    Int J Cancer. 2017 Jul 8. doi: 10.1002/ijc.30880.
    PubMed     Text format     Abstract available


    June 2017
  20. HOLZINGER D, Wichmann G, Baboci L, Michel A, et al
    Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2017;140:2748-2757.
    PubMed     Text format     Abstract available


  21. BOSCOLO-RIZZO P, Dietz A
    The AJCC/UICC eighth edition for staging head and neck cancers: Is it wise to de-escalate treatment regimens in p16-positive oropharyngeal cancer patients?
    Int J Cancer. 2017 Jun 14. doi: 10.1002/ijc.30837.
    PubMed     Text format    


  22. YOU R, Sun R, Hua YJ, Li CF, et al
    Cetuximab or Nimotuzumab plus Intensity-modulated Radiotherapy Versus Cisplatin plus Intensity-modulated Radiotherapy for Stage II-IVb Nasopharyngeal Carcinoma.
    Int J Cancer. 2017 Jun 2. doi: 10.1002/ijc.30819.
    PubMed     Text format     Abstract available


    May 2017
  23. KLINGHAMMER K, Otto R, Raguse JD, Albers AE, et al
    Basal subtype is predictive for response to cetuximab treatment in patient derived xenografts of squamous cell head and neck cancer.
    Int J Cancer. 2017 May 30. doi: 10.1002/ijc.30808.
    PubMed     Text format     Abstract available


  24. CARIOLI G, Negri E, Kawakita D, Garavello W, et al
    Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: Focus on low-risk areas.
    Int J Cancer. 2017;140:2256-2264.
    PubMed     Text format     Abstract available


  25. BALERMPAS P, Rodel F, Krause M, Linge A, et al
    The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Int J Cancer. 2017 May 8. doi: 10.1002/ijc.30770.
    PubMed     Text format     Abstract available


    April 2017
  26. RENKONEN S, Lee M, Makitie A, Lindstrom LS, et al
    Site-specific familial risk and survival of familial and sporadic head and neck cancer.
    Int J Cancer. 2017 Apr 25. doi: 10.1002/ijc.30751.
    PubMed     Text format     Abstract available


  27. LU Z, Zhang C, Sheng J, Shen J, et al
    T cell receptor beta-chain repertoire analysis reveals the association between neoantigens and tumour-infiltrating lymphocytes in multifocal papillary thyroid carcinoma.
    Int J Cancer. 2017 Apr 21. doi: 10.1002/ijc.30743.
    PubMed     Text format     Abstract available


  28. DE MARTEL C, Plummer M, Vignat J, Franceschi S, et al
    Worldwide burden of cancer attributable to HPV by site, country and HPV type.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30716.
    PubMed     Text format     Abstract available


    March 2017
  29. GHEIT T, Anantharaman D, Holzinger D, Alemany L, et al
    Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India.
    Int J Cancer. 2017 Mar 29. doi: 10.1002/ijc.30712.
    PubMed     Text format     Abstract available


  30. PRIGGE ES, Arbyn M, von Knebel Doeberitz M, Reuschenbach M, et al
    Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
    Int J Cancer. 2017;140:1186-1198.
    PubMed     Text format     Abstract available


  31. SCHNELLE C, Whiteman DC, Porceddu SV, Panizza BJ, et al
    Past sexual behaviors and risks of oropharyngeal squamous cell carcinoma: a case-case comparison.
    Int J Cancer. 2017;140:1027-1034.
    PubMed     Text format     Abstract available


    February 2017
  32. SUGASE T, Takahashi T, Serada S, Nakatsuka R, et al
    Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
    Int J Cancer. 2017 Feb 24. doi: 10.1002/ijc.30666.
    PubMed     Text format     Abstract available


  33. JEHANNIN-LIGIER K, Belot A, Guizard AV, Bossard N, et al
    Incidence Trends for Potentially Human Papilloma Virus-Related and -Unrelated Head and Neck Cancers in France using Population-based Cancer Registries Data: 1980-2012.
    Int J Cancer. 2017 Feb 6. doi: 10.1002/ijc.30631.
    PubMed     Text format     Abstract available


  34. LIEDERBACH E, Kyrillos A, Wang CH, Liu JC, et al
    The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.
    Int J Cancer. 2017;140:504-512.
    PubMed     Text format     Abstract available


    January 2017
  35. ANANTHARAMAN D, Abedi-Ardekani B, Beachler DC, Gheit T, et al
    Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer.
    Int J Cancer. 2017 Jan 20. doi: 10.1002/ijc.30608.
    PubMed     Text format     Abstract available


    December 2016
  36. HATANO T, Sano D, Takahashi H, Hyakusoku H, et al
    Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30589.
    PubMed     Text format     Abstract available


    November 2016
  37. ROTTENBERG Y, Levine H, Keinan-Boker L, Derazne E, et al
    Risk of nasopharyngeal carcinoma penetrates across immigrant generations: A migrant cohort study of 2.3 million Jewish Israeli adolescents.
    Int J Cancer. 2016 Nov 16. doi: 10.1002/ijc.30525.
    PubMed     Text format     Abstract available


    October 2016
  38. MAO L, Deng WW, Yu GT, Bu LL, et al
    Inhibition of SRC family kinases reduces myeloid-derived suppressor cells in head and neck cancer.
    Int J Cancer. 2016 Oct 31. doi: 10.1002/ijc.30493.
    PubMed     Text format     Abstract available


  39. CHEN X, Yuan Z, Lu M, Zhang Y, et al
    Poor oral health is associated with an increased risk of esophageal squamous cell carcinoma - a population-based case-control study in China.
    Int J Cancer. 2016 Oct 25. doi: 10.1002/ijc.30484.
    PubMed     Text format     Abstract available


    September 2016
  40. RAMAYANTI O, Juwana H, Verkuijlen SA, Adham M, et al
    Epstein-Barr Virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
    Int J Cancer. 2016 Sep 7. doi: 10.1002/ijc.30418.
    PubMed     Text format     Abstract available


    August 2016
  41. LIU Z, Coghill AE, Pfeiffer RM, Hsu WL, et al
    Birth order and risk of nasopharyngeal carcinoma in multiplex families from Taiwan.
    Int J Cancer. 2016 Aug 18. doi: 10.1002/ijc.30390.
    PubMed     Text format     Abstract available


  42. GARNAES E, Frederiksen K, Kiss K, Andersen L, et al
    Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study.
    Int J Cancer. 2016 Aug 18. doi: 10.1002/ijc.30389.
    PubMed     Text format     Abstract available


    July 2016
  43. VON MASSENHAUSEN A, Sanders C, Bragelmann J, Konantz M, et al
    Targeting DDR2 in Head and Neck Squamous Cell Carcinoma with Dasatinib.
    Int J Cancer. 2016 Jul 19. doi: 10.1002/ijc.30279.
    PubMed     Text format     Abstract available


  44. GUO T, Gaykalova DA, Considine M, Wheelan S, et al
    Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2016;139:373-82.
    PubMed     Text format     Abstract available


    May 2016
  45. CHIN YM, Ping Tan L, Abdul Aziz N, Mushiroda T, et al
    Integrated pathway analysis of nasopharyngeal carcinoma implicates the axonemal dynein complex in the Malaysian cohort.
    Int J Cancer. 2016 May 28. doi: 10.1002/ijc.30207.
    PubMed     Text format     Abstract available


  46. LAPRISE C, Puthiyannal Shahul H, Arekunnath Madathil S, Soman Thekkepurakkal A, et al
    Periodontal diseases and risk of oral cancer in Southern India: Results from the HeNCe Life study.
    Int J Cancer. 2016 May 23. doi: 10.1002/ijc.30201.
    PubMed     Text format     Abstract available


  47. WAGNER S, Wittekindt C, Reuschenbach M, Hennig B, et al
    CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2016;138:2263-73.
    PubMed     Text format     Abstract available


    March 2016
  48. SHOULTZ-HENLEY S, Garden AS, Mohamed AS, Sheu T, et al
    Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation.
    Int J Cancer. 2016;138:1290-7.
    PubMed     Text format     Abstract available


  49. ZHU DD, Zhang J, Deng W, Yip YL, et al
    Significance of NF-kappaB activation in immortalization of nasopharyngeal epithelial cells.
    Int J Cancer. 2016;138:1175-85.
    PubMed     Text format     Abstract available


    February 2016
  50. WANG HM, Cheng NM, Lee LY, Fang YH, et al
    Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma.
    Int J Cancer. 2016;138:731-8.
    PubMed     Text format     Abstract available


    January 2016
  51. VOJTECHOVA Z, Sabol I, Salakova M, Turek L, et al
    Analysis of the integration of human papillomaviruses in head and neck tumours in relation to patients' prognosis.
    Int J Cancer. 2016;138:386-95.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: